tiprankstipranks
Trending News
More News >
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market

Gland Pharma Ltd. (GLAND) Income Statement

Compare
1 Followers

Gland Pharma Ltd. Income Statement

Last quarter (Q1 2026), Gland Pharma Ltd.'s total revenue was ₹15.06B, an increase of 7.41% from the same quarter last year. In Q1, Gland Pharma Ltd.'s net income was ₹2.15B. See Gland Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 56.17B₹ 56.65B₹ 36.25B₹ 44.01B₹ 34.63B
Gross Profit
₹ 31.54B₹ 31.11B₹ 17.65B₹ 21.51B₹ 18.53B
Operating Expenses
₹ 14.17B₹ 12.88B₹ 6.08B₹ 5.67B₹ 4.34B
Depreciation and Amortization
₹ 3.59B₹ 3.25B₹ 1.47B₹ 1.10B₹ 985.75M
EBITDA
₹ 12.31B₹ 12.97B₹ 10.31B₹ 15.10B₹ 13.02B
Operating Income
₹ 17.38B₹ 18.23B₹ 11.57B₹ 15.84B₹ 14.19B
Other Income/Expenses
₹ -6.75B₹ -6.90B₹ -1.02B₹ 345.87M₹ -839.40M
Pretax Income
₹ 10.63B₹ 11.33B₹ 10.55B₹ 16.19B₹ 13.35B
Net Income
₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B₹ 9.97B
Per Share Metrics
Basic EPS
₹ 42.40₹ 46.90₹ 47.44₹ 73.81₹ 63.07
Diluted EPS
₹ 42.40₹ 46.89₹ 47.43₹ 73.64₹ 62.99
Weighted Average Shares Outstanding
164.75M 164.74M 164.67M 164.54M 158.27M
Weighted Average Shares Outstanding (Diluted)
164.75M 164.73M 164.68M 164.54M 158.28M
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History